drugset / Trial / NCT05600673

Combined CO2 Fractional Laser With Bimatoprost 0.03% Treatment of Alopecia Areata

NCT05600673

Phase 1/2 Completed 30 enrolled Ahmed Hassan Nouh MD
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this study is to evaluate the efficacy and safety of combined CO2 fractional laser with Bimatoprost 0.03% as novel treatment of alopecia areata. The main question to study is will the bimatoprost facilitate hair growth if added to fractional CO2 laser treatment in Alopecia areata.

Timeline

Start
2019-01-01
Primary completion
2021-01-30
Completion
2021-05-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 0.03 % Topical

Indications